Admelog and Omalizumab Subcutaneous
Determining the interaction of Admelog and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: n.a.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Admelog-Ombitasvir, Paritaprevir, and Ritonavir
- Admelog-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Admelog-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Admelog-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Admelog-Omeclamox-Pak
- Admelog-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Admelog (Insulin Lispro (U-100) Cartridges and Pens)
- Omalizumab Subcutaneous-Admelog (Insulin Lispro (U-100) Vials)
- Omalizumab Subcutaneous-Ado-trastuzumab emtansine
- Omalizumab Subcutaneous-Ado-trastuzumab emtansine Intravenous
- Omalizumab Subcutaneous-Adox Pak 2/100
- Omalizumab Subcutaneous-Adoxa